Latest Market Research Reports

  Ophthalmic Drugs Market Summary The global  ophthalmic drugs market  size was estimated at USD 38.20 billion in 2024 and is projected to reach USD 62.08 billion by 2030, growing at a CAGR of 8.5% from 2025 to 2030. This growth is largely driven by the rising prevalence of eye diseases, improvements in drug delivery technologies, and an increasing emphasis on research aimed at developing innovative therapeutics. As the burden of conditions such as glaucoma, macular degeneration, and diabetic retinopathy continues to rise, ophthalmic drugs play an increasingly vital role in preserving vision and enhancing quality of life for patients worldwide. Moreover, increasing investment by public and private organizations is further propelling market expansion. These investments support clinical research, product development, and advanced treatment approaches. For instance, in July 2023, the National Eye Institute announced funding of USD 2.5 million spread over 5 years to support r...

  Ophthalmic Drugs Market Summary The global  ophthalmic drugs market  size was estimated at USD 38.20 billion in 2024 and is projected to reach USD 62.08 billion by 2030, growing at a CAGR of 8.5% from 2025 to 2030. The market growth is attributed to rising eye disease prevalence, advancement in drug delivery, and an increasing focus on research for the development of novel therapeutics in the market. The growing elderly population, higher screen-time exposure, and lifestyle-related disorders are also contributing to the higher incidence of vision impairment and ocular conditions worldwide, supporting demand for effective ophthalmic drugs. Moreover, increasing investment by public and private organizations is further propelling the growth of the market. For instance, in July 2023, the National Eye Institute announced a funding of USD 2.5 million for over 5 years to advance the glaucoma treatment research at Missouri University of Science and Technology. Continuous innova...

Ophthalmic Drugs Industry Overview The global  ophthalmic drugs market  size is expected to reach USD 60.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.4% from 2021 to 2028. An increase in the prevalence of eye-related disorders, such as presbyopia, macular degeneration, and  diabetic retinopathy , is one of the major drivers of the market. According to the American Academy of Ophthalmology, over 2.71 million people in the U.S. were affected by Primary Open-angle Glaucoma (POAG) in 2011, and the number is estimated to reach 7.3 million by 2050. Ophthalmic Drugs Market Segmentation Grand View Research has segmented the global ophthalmic drugs market on the basis of drug class, disease, dosage form, route of administration, product type, and region. Based on the Drugs Class Insights, the market is segmented into Antiallergy, Anti-VEGF Agents, Anti-inflammatory, Antiglaucoma, Others. The...